Fig. 2From: Repurposing Probenecid for the Treatment of Heart Failure (Re-Prosper-HF): a study protocol for a randomized placebo-controlled clinical trialSchematic of study design for the Re-Prosper-HF Trial. Study flow diagram summarizing major inclusion criteria, screening, randomization, stratification by site, and study visits. HFrEF, heart failure with reduced ejection fraction; EF, ejection fraction; GDMT, guideline-directed medical therapy; VA, Veterans Affairs Hospital; BID, twice daily; Screen, screening visit; IC, informed consent; Rand, randomizationBack to article page